Yüklüyor......
Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients
AIMS: Naloxegol, a polyethylene glycol conjugated derivative of the opioid antagonist naloxone, is in clinical development for treatment of opioid‐induced constipation (OIC). The aim of the study was to develop a population pharmacokinetic model describing the concentration vs. time profile of orall...
Kaydedildi:
| Yayımlandı: | Br J Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4693583/ https://ncbi.nlm.nih.gov/pubmed/26317320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12756 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|